Method of inhibiting fibrosis
CA 2107371 A1 · Owner: Murad, Saood · Inventors: Murad, Saood; Pinnell, Sheldon R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed is a method of inhibiting fibrosis in a human or animal subject afflicted with a fibrosing disorder. The method comprises administering to the subject an effective fibrosis-inhibiting amount of a compound of formula (I), wherein: n is 1 or 2 R is, selected from the group consisting of hydrogen C1-C4 alkyl, hydroxy, amino, and nitro; and R' is selected from the group consisting of hydrogen and C1-C4 alkyl, or a pharmaceutically acceptable salt thereof. Preferred as a compound of formula (I) is benzoic hydrazide. Pharmaceutical formulations and the use of compounds of formula (I) for making the same are also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 31, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 31, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 31, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.